Premium
Ketoconazole differentially inhibits zolpidem and triazolam biotransformation: In vitro mechanism and in vivo consequence
Author(s) -
Greenblatt D.J.,
Moltke L.L.,
Harmatz J.S.,
Granda B.W.,
Shader R.I.
Publication year - 1999
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1016/s0009-9236(99)80102-7
Subject(s) - triazolam , zolpidem , pharmacology , ketoconazole , in vivo , biotransformation , in vitro , chemistry , mechanism (biology) , medicine , biology , benzodiazepine , receptor , biochemistry , antifungal , philosophy , microbiology and biotechnology , epistemology , dermatology , enzyme , insomnia
Clinical Pharmacology & Therapeutics (1999) 65 , 142–142; doi: